Fase II Comparative Study of the Efficacy and Safety of PRO-148 Ophthalmic Solution vs Systane in the Treatment of Mild-to-moderate Eye Syndrome.
Phase of Trial: Phase II
Latest Information Update: 08 Nov 2018
Price : $35 *
At a glance
- Drugs PRO 148 (Primary) ; Polyethylene glycols; Propylene glycol
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Laboratorios Sophia
- 08 Feb 2018 Status changed from active, no longer recruiting to completed.
- 11 Apr 2014 New trial record